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Rett syndrome is a severe neurodevelopmental disease caused by mutations in the X-linked gene encoding for the methyl-CpG-binding
protein MeCP2. Here, we report the identiﬁcation of FOXG1-truncating mutations in two patients affected by the congenital variant of
Rett syndrome. FOXG1 encodes a brain-speciﬁc transcriptional repressor that is essential for early development of the telencephalon.
Molecular analysis revealed that Foxg1 might also share common molecular mechanisms with MeCP2 during neuronal development,
exhibiting partially overlapping expression domain in postnatal cortex and neuronal subnuclear localization.In the classic form of Rett syndrome (RTT [MIM 312750]),
females are heterozygous for mutations in the X-linked
MECP2 gene (MIM 300005) and the few reported males
have an XXY karyotype or MECP2 mutations in a mosaic
state.1 A number of variants have been described including
the congenital, the early-onset seizures, and the preserved
speech variant.2 Soon after the discovery of MECP2 as the
RTT gene, we demonstrated that the preserved speech var-
iant is allelic to the classic form.3 More recently, we and
others showed that CDKL5 (MIM 300203) is responsible
for atypical RTT, namely the early-onset seizures variant.4,5
The congenital variant was initially described by Rolando
in 1985.6 In this form, girls are ﬂoppy and retarded from
the very ﬁrst months of life. The majority of congenital
variants do not bear MECP2 or CDKL5 mutations,7,8 with
only four cases being reported with MECP2mutations.9–11
Using oligo array CGH, we recently identiﬁed a de novo
3 Mb interstitial deletion of chromosome 14q12 in a 7
year-old girl.12 She showed dysmorphic features and
a Rett-like clinical course, including normal perinatal pe-
riod, postnatal microcephaly, seizures, and severe mental
retardation. The deleted region was gene poor and con-
tained only ﬁve genes. Among them, FOXG1 (MIM
164874) turned out to be a very interesting gene because
it encodes a brain-speciﬁc transcriptional repressor. We an-
alyzed this gene with a combination of both DHPLC and
real-time quantitative PCR in a cohort of 53 MECP2/
CDKL5 mutation-negative RTT patients, including seven
classic, 21 preserved speech, seven early-onset seizures,
one ‘‘forme fruste,’’ two congenital variants and 15 Rett-
like cases.13 For real-time qPCR analysis, we designed
primers and TaqMan probe complementary to a segment
located in the middle of the single exon of the gene using
Primer Express software (Applied Biosystems). Sequences
of primers and probe (FAM labeled) are listed in Table S1
available online. We used an RNAase P kit as an internal
reference (VIC-labeled probe, Applied Biosystems). PCR
was carried out as previously described.14 The starting
copy number of the unknown samples was determined
with the comparative Ct method, as reported by Livak.15
By DHPLC, we identiﬁed a different de novo FOXG1 trun-
cating mutation in the two congenital variant patients.
Real-time qPCR failed to identify any microdeletion in
the 53 patients.
FOXG1 encodes forkhead box protein G1, FoxG1 (for-
merly brain factor 1 [BF-1]), a transcriptional factor with
expression restricted to fetal and adult brain and testis.
FoxG1 interacts with the transcriptional repressor JARID1B
and with global transcriptional corepressors of the Grou-
cho family. The interaction with these proteins is of func-
tional importance for early brain development.16,17 Like
MeCP2, FoxG1 also indirectly associates with the histone
deacetylase 1 protein.1,17 Both mutations disrupted the
protein at different levels (Figure 1). In case 1, a stop-codon
mutation p.W255X (c.765G/A) impaired the DNA bind-
ing because of the disruption of the forkhead domain
(Figure 1D, left). Case 2 showed a 1 bp deletion c.969
delC (p.S323fsX325) causing the loss of JARID1B-interact-
ing domain and themisfolding of themotif responsible for
the Groucho binding (Figure 1D, right). Lastly, both
FOXG1mutations affected all the four brain fetal isoforms
that lack the last 37 amino acids and have different C-ter-
minal domains.18
The two mutated individuals, aged 22 (case 1) and 7
years (case 2), fulﬁlled the international criteria for RTT
variants.19 Pregnancy, delivery, and auxological parame-
ters at birth were normal. Neurological and behavioral neo-
natal evaluations were reported as normal, but at three
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Figure 1. FOXG1 Mutations and Alterations of the Functional
Domains
(A) Sequence tracing of FOXG1 mutations in the two patients.
Mutated bases are indicated above the line.
(B) Schematic representation of FoxG1 protein. The three main
functional domains are shown: the DNA binding fork-head domain
in light blue (FHD), the Groucho-binding domain in violet (GTBD),
and the JARID1B binding domain in red (JBD). The numbers at the
top refer to the amino acid positions. Mutations are indicated by
zigzag lines.
(C and D) Ribbon representation of the tertiary structure obtained
with Phyre v.0.2 software. (C) shows the structure of the region
containing the three functional domains of wild-type protein
(amino acids 180–489). Arrows highlight the two mutations. The
FHD domain (cyan) consists of three alpha helices and one beta
hairpin (two beta strands and one loop), whereas the GTBD (violet)
and JBD (red) domains are random coiled. (D) shows structural
modification after p.W255X (left) and p.S323fsX325 (right) muta-
tions. The p.W255X mutation determines a protein truncation just
after the second beta strand leading to the loss of the beta hairpin
and thus preventing DNA binding. The p.S323fsX325 mutation
leaves the FHD domain intact and truncates the protein just
after GTBD, inducing conformational changes that lead to its
misfolding.90 The American Journal of Human Genetics 83, 89–93, July 2008months, an abnormal head-circumference growing was
noticed in the patients. These patients appeared to weep
inconsolably, and they did not respond when called and
were unable to lift their heads. Case 1 was never able to
sit unaided and laid permanently in bed, whereas case 2
was barely able to sit. They were always apraxic and from
1 year of age, they showed peculiar jerky movements of
the upper limbs and midline stereotypic activities, typical
of RTT syndrome (Figure 2). They never acquired spoken
language. Generalized convulsions appeared at 14 years
in case 1 and at 2 1/2 years in case 2. Ever since cases 1
and 2 were 3 and 5 years old, respectively, an EEG showed
features often found in RTT patients: a multifocal pattern
with spikes and sharp waves and occasional paroxysmal
activity. In both patients brain MRI showed corpus cal-
losum hypoplasia, a ﬁnding which has already been re-
ported in RTT.20 Currently, they show microcephaly
(OFC of 49 cm in case 1, and 47 cm in case 2). They have
occasional periods of deep breathing with exaggerated in-
spirations. Sialorrhoea, bruxism, scoliosis, and cold lower
extremities as well as stypsis are present in both patients
who are currently fed by mouth.
These two girls show neurological and neurovegetative
symptoms as well as somatic features consistent with a di-
agnosis of congenital RTT variant. It should only be noted
that a retrospective assessment concerning the possible
presence of a regression was not feasible. We attempted
to compare their phenotype with the four other MECP2-
mutated girls described as congenital variants.9–11 How-
ever, they have been reported with very little detail,
thereby hampering a posteriori clinical re-evaluation ac-
cording to the revised criteria.19 According to the new cri-
teria, in the classic form, psychomotor development may
have been delayed from birth; thus, a re-evaluation of
these four patients would have lead to their reclassiﬁcation
as classic form. Alternatively, the disruption of either
MeCP2 or FoxG1 may lead to a phenotype, namely the
congenital variant, indistinguishable at the level of the
clinical and instrumental investigations performed.
A translocation with inversion affecting fetal isoforms of
FOXG1 was recently described in a 7-year-old girl.18 She
had acquired microcephaly, alalia, inability to sit and
walk, and epilepsy in common with the present cases. Cor-
pus callosumwas absent, whereas in our cases, it was hypo-
plasic. Stereotypic hand activities were not mentioned,
and tetraplegia was described.18 The clinical features of
this patient have something in common with a RTT phe-
notype. The impairment of only fetal FOXG1 isoforms
and the possible contribution of genes at the other two
breakpoints of the complex rearrangement might explain
the phenotypic differences.
The mouse ortholog Foxg1 has a restricted expression
domain in the central nervous system coinciding with
the emergence of the telencephalic structures of the brain.
Its function has been extensively characterized and found
to promote telencephalon development by sustaining
proliferation of the progenitor pool and preventing
Figure 2. Pictures of the Two Congeni-
tal RTT Patients
Case 1 (#156) is shown on the left; case 2
(#868) is shown on the right. They show
peculiar jerky movements of the upper
limbs frequently pushed in different direc-
tions accompanied by continuous flexion-
extension, wringing movements of the fin-
gers of the hands. The hands were brought
together in hand-washing and hand-mouth
stereotypic activities, which were intense
and present all the time they were awake.
Similar flexion-extension movements of
the toes were noticed in the feet. The dou-
ble scoliosis of case 1 is clearly evident,
whereas the other girl maintained a
straight vertebral column as often occurs
in RTT in the first decade. Teeth grinding
was present, and the tongue often pro-
truded out from the mouth.premature cortical neural differentiation.21,22 In agree-
ment, FoxG1 expression is found in the proliferating neu-
roepithelium starting from early development onward.23
This expression proﬁle might explain the particular early
onset of the neurological symptoms displayed by the
patients.
Despite its early expression in telencephalon develop-
ment, in this study we found that Foxg1 expression is de-
tectable in the differentiating cortical compartment in
the postnatal stages, although at lower levels with respect
to the early embryonic phases (Figure 3A). This expression
proﬁle overlaps with the described MeCP2 expression
Figure 3. FoxG1 and MeCP2 Expression
Domain in Postnatal Cortex and Neuronal
Subnuclear Localization
(A and B) Expression analysis by in situ hy-
bridization of Foxg1 and MeCP2 on P8 post-
natal forebrain tissue. As shown in (A),
Foxg1 expression is found in differentiat-
ing and mature cortical neurons in the de-
finitive cortical plate (indicated by arrows
in [A]) similar to the MeCP2 expression
pattern (indicated by arrows in [B]). In
(A0), the inset shows background staining
with a sense cRNA for Foxg1 in the same
in situ hybridization conditions used for
(A) and (B).
(C–J) FoxG1 and MeCP2 sub-cellular locali-
zation in non-neural and primary neurons.
As shown in (C)–(F), in NIH 3T3 cells,
MeCP2-GFP exogenous protein has a diffuse
nuclear localization with accumulation in
the heterochromatic foci (indicated by ar-
rows in [D]) as identified when compared
with DAPI staining (indicated by arrows
in [C]). (E) and (F) show that conversely,
FoxG1-flag exogenous protein displays
a widespread nuclear localization without
enrichment in heterochromatic sites. (G)–
(J) show FoxG1 and MeCP2 localization in
12DIV (days in vitro) primary hippocampal neurons. In (G), MeCP2 endogenous protein is accumulated in heterochromatic foci (indicated
by arrows). As shown in (H), FoxG1-flag exogenous nuclear localization is excluded from heterochromatic puncta (indicated by arrow-
heads). As shown in (I), MeCP2 and FoxG1-flag colocalize in the nuclear compartment outside the heterochromatic foci. As shown in
(J), Nuclear FoxG1-flag localization is detected in a differentiated b-III-tubulin-positive neuron. The following abbreviations are
used: cx, cerebral cortex; se, septum; str, striatum; and v, ventricle.The American Journal of Human Genetics 83, 89–93, July 2008 91
domain in cortical tissues, in differentiating and mature
neurons (Figures 3A and 3B). Foxg1 homozygote-mutant
mice die shortly after birth with severe brain defects.24–26
Unfortunately, the severe compromised development of
Foxg1 mutant telencephali has prevented the analysis of
its function in more differentiated neurons. At the single-
cell level, FoxG1 localizes in the nuclear compartment
but is excluded from the MeCP2-positive heterochromatic
foci both in nonneural and primary neurons (Figures 3C–
3J). These ﬁndings suggest that, differently from MeCP2,
FoxG1 is not a transcriptional repressor stably associated
with heterochromatin. However, both proteins have a large
colocalization domain in other nuclear compartments
(Figure 3I).
Overall, these data suggest that FoxG1 may exert some
additional functions in differentiating and mature neu-
rons, thus sharing similarities with those described for
MeCP2. These ﬁndings may provide some biological
evidence for the development of similar clinical manifesta-
tions in disorders affecting the two genes. However, it is
also possible that the two transcriptional regulators act
on different stages of the process that leads to proper corti-
cal development, from early cell-fate decisions to later cir-
cuit connectivity and dendritic development.
FoxG1 shares some interesting analogies with MeCP2 in
its molecular functions, raising the question whether the
two protein networks may interact in some circumstances
and on selective common targets. Future studies will ad-
dress this intriguing hypothesis. Recently, heterozygous
Foxg1þ/ mice were found to display subtler defects in-
cluding a reduction in size of the corpus callosum to-
gether with speciﬁc patterning defects.25,27 Furthermore,
heterozygous Foxg1þ/ exhibit learning deﬁcits based on
fear-condition behavioral tests associated with a loss of
postnatal neurogenesis in the hippocampus.27 These
mice represent a very interesting animal model for further
investigation about how Foxg1 haploinsufﬁciency may
impact on brain development and neuronal maturation
and function.
In conclusion, we demonstrated that FOXG1 is a previ-
ously unrecognized gene responsible for variant Rett syn-
drome. It is worth noting that in the revised criteria for
Rett syndrome the female sex is no longer present as inclu-
sion criteria.19 This seemed to open the door to the discov-
ery of an autosomal gene.
Supplemental Data
One table listing primers and probes for real-time qPCR is available
at http://www.ajhg.org/.
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